Volitionrx limited announces pricing of $6 million underwritten public offering of common stock

Henderson, nev. , july 29, 2022 /prnewswire/ -- volitionrx limited (nyse american: vnrx) ("volition"), a multi-national epigenetics company, announced today the pricing of its underwritten public offering of 3,000,000 shares of its common stock at a public offering price of $2.00 per share.
VNRX Ratings Summary
VNRX Quant Ranking